2 of Wall Street’s Favorite Stocks to Target This Week and 1 We Brush Off

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. Keeping that in mind, here are two stocks likely to meet or exceed Wall Street’s lofty expectations and one where analysts may be overlooking some important risks.

One Stock to Sell:

LifeStance Health Group (LFST)

Consensus Price Target: $9.83 (42.6% implied return)

With over 6,600 licensed mental health professionals treating more than 880,000 patients annually, LifeStance Health (NASDAQ:LFST) provides outpatient mental health services through a network of clinicians offering psychiatric evaluations, psychological testing, and therapy across 33 states.

Why Does LFST Worry Us?

1. Smaller revenue base of $1.42 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
2. Low free cash flow margin of 0.5% for the last five years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
3. Negative returns on capital show that some of its growth strategies have backfired

LifeStance Health Group is trading at $6.90 per share, or 22.9x forward P/E. To fully understand why you should be careful with LFST, check out our full research report (it’s free).

Two Stocks to Buy:

Meta (META)

Consensus Price Target: $855.11 (27.1% implied return)

Famously founded by Mark Zuckerberg in his Harvard dorm, Meta Platforms (NASDAQ:META) operates a collection of the largest social networks in the world - Facebook, Instagram, WhatsApp, and Messenger, along with its metaverse focused Reality Labs.

Why Will META Beat the Market?

1. Monetization efforts are paying off as its average revenue per user has grown by 29.9% annually over the last two years
2. Share repurchases over the last three years enabled its annual earnings per share growth of 51.3% to outpace its revenue gains
3. Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends, and its improved cash conversion implies it’s becoming a less capital-intensive business

At $672.76 per share, Meta trades at 12.2x forward EV/EBITDA. Is now a good time to buy? See for yourself in our full research report, it’s free.

Permian Resources (PR)

Consensus Price Target: $24.90 (22% implied return)

Controlling roughly 450,000 net acres in America's most productive oil patch, Permian Resources (NYSE:PR) is an oil and natural gas producer that drills wells and extracts hydrocarbons from underground reservoirs in West Texas and New Mexico.

Why Should You Buy PR?

1. Annual revenue growth of 43.3% over the last ten years was superb and indicates its market share increased during this cycle
2. Highly-profitable operating model results in strong unit economics and a best-in-class gross margin of 75.7%
3. Robust free cash flow margin of 27.2% gives it many options for capital deployment

Permian Resources’s stock price of $20.40 implies a valuation ratio of 10.4x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.